What this study is
ariessence is intended to be used as a viscous, leave-on solution designed for topical application to the face. It is intended to be used following non-medical cosmetic procedures, performed by licensed healthcare professionals to enhance comfort and maintain skin hydration. This study is designed to be a multi-center, post-market cosmetic evaluation of ariessence applied to the full face after an ablative laser procedure to evaluate improvements in procedure tolerability and improvements in the appearance of the skin, compared to an emollient control.
What's being tested
- ariessence pure PDGF+™ is a sterile aqueous formulation containing Hyaluronic Acid and pure platelet-derived growth factor (PDGF).
Intervention · OTHER
To compare time to appearance-based recovery and subject satisfaction between ariessence and standard of care groups using standardized photographs and investigator/subject ratings for tolerability and satisfaction
Study details
- Official title
- A Multi-center, Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser for the Tolerability and Improvement in the Appearance of Aging Skin.
- Sponsor
- Lynch Regenerative Medicine
- Conditions
- Immediate Post-Treatment Care · Aging Mid-Face · Aging
- Enrolling
- 21 people
- Starts
- 2026-04-16
- Est. completion
- 2027-02
- Design
- Triple-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 40 Years – 70 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- -:Adults 40-65 70 years
- Glogau III-IV
- Fitzpatrick II-IV.
- Suitable for ablative laser
- Non-smoker ≥ 3 years
- Willing to comply with post-procedure regimen
- Patient reported outcome documentation, and photo documentation.
You can't join if
- Fitzpatrick I or > IV,
- Recent facial procedures (< 6 months)
- Active skin disease
- Pregnancy/lactation
- Implanted devices
- History of keloids.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
2 openLaser & Skin Surgery Medical Group
Sacramento, California, United States
- Suzanne Kilmer, MD · Contact916-456-0400 ext. 216Nathan.Smith@purity-health.com
RecruitingThe Practice of Brian S. Biesman, MD
Nashville, Tennessee, United States
- Brian S Biesman, MD · Contact615-329-1110Nathan.Smith@purity-health.com
Recruiting
Study team
Sponsor
Lynch Regenerative Medicine
Study ID LRM-ARS-PLF 401
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.